Agilysys Inc: Form 10-Q for the period ended Dec 31, 2024
Filed with the SEC on Jan 21, 2025 and accepted by EDGAR at Jan 21, 2025, 16:11 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-10-01 to 2024-12-31 | $69.6m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2024-04-01 to 2024-12-31 | $201.4m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2024-10-01 to 2024-12-31 | $25.7m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2024-04-01 to 2024-12-31 | $74.4m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2024-10-01 to 2024-12-31 | $43.9m | us-gaap:GrossProfit |
| Gross profit | 9 months2024-04-01 to 2024-12-31 | $126.9m | us-gaap:GrossProfit |
| Research and development | 3 months2024-10-01 to 2024-12-31 | $15.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2024-04-01 to 2024-12-31 | $45.9m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2024-10-01 to 2024-12-31 | $36.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2024-04-01 to 2024-12-31 | $109.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2024-10-01 to 2024-12-31 | $7.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2024-04-01 to 2024-12-31 | $17.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2024-10-01 to 2024-12-31 | $657.0k | us-gaap:InterestExpense |
| Interest expense | 9 months2024-04-01 to 2024-12-31 | $1.1m | us-gaap:InterestExpense |
| Income tax | 3 months2024-10-01 to 2024-12-31 | $3.9m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2024-04-01 to 2024-12-31 | $962.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-10-01 to 2024-12-31 | $3.8m | us-gaap:NetIncomeLoss |
| Net income | 9 months2024-04-01 to 2024-12-31 | $19.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-10-01 to 2024-12-31 | $0.14 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2024-04-01 to 2024-12-31 | $0.68 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-10-01 to 2024-12-31 | $0.14 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2024-04-01 to 2024-12-31 | $0.70 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-10-01 to 2024-12-31 | 28,314,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2024-04-01 to 2024-12-31 | 28,248,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2024-04-01 to 2024-12-31 | $28.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2024-04-01 to 2024-12-31 | $2.1m | us-gaap:PaymentsToAcquireProductiveAssets |
| Cash and equivalents | At period end2024-12-31 | $60.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-12-31 | $131.2m | us-gaap:AssetsCurrent |
| Total assets | At period end2024-12-31 | $443.9m | us-gaap:Assets |
| Current liabilities | At period end2024-12-31 | $115.0m | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2024-12-31 | $38.0m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2024-12-31 | $256.8m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000950170-25-007222. Last ingested by Listed: Nov 2, 2026, 12:28 ET. Listed shows no prices and gives no investment advice.